Source: MarketScreener

Alder BioPharmaceuticals: INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alder BioPharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

(marketscreener.com) The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Alder BioPharmaceuticals, Inc. ("Alder" or "the Company") (NASDAQ: ALDR) for potential breaches of fiduciary duty on the part of its directors in connection with the pending sale of the...http://www.marketscreener.com/ALDER-BIOPHARMACEUTICALS-16421407/news/INVESTIGATION-ALERT-The-Schall-Law-Firm-Announces-it-is-Investigating-Claims-Against-Alder-BioPharm-29323036/?utm_medium=RSS&utm_content=20191001

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Robert W. Azelby's photo - President & CEO of Alder BioPharmaceuticals

President & CEO

Robert W. Azelby

CEO Approval Rating

82/100

Read more